Prognostic analysis of first-recurrence/metastasis esophageal squamous cell carcinoma: chemoimmunotherapy combined with radiotherapy as one of the optimal clinical management strategies - Top-Institutions - MDSpire

Prognostic Evaluation of First Recurrence or Metastasis in Esophageal Squamous Cell Carcinoma: The Role of Combined Chemoimmunotherapy and Radiotherapy in Optimal Treatment Approaches

By
Yitong Li
Qiaofang Li
Kuo Wang
Mengchang Gao
Lei Tian
Miaomiao Liu
Yuqing Bu
Yujie Cui
July 21, 2026

Frontiers In Immunology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Hebei General Hospital

Shijiazhuang, Hebei
Key Differentiators
- Oncology
#2

Sichuan Cancer Hospital

Chengdu, Sichuan
Key Differentiators
- Oncology
#3

Bielefeld University, Medical School

Bielefeld, North Rhine-Westphalia
Key Differentiators
- Oncology
#4

University Medical Center OWL, Campus Hospital Lippe, Detmold

Detmold, North Rhine-Westphalia
Key Differentiators
- Oncology
#5

Shanghai Chest Hospital

Shanghai, Shanghai
Key Differentiators
- Oncology

Original Source(s)

Frontiers In Immunology

Prognostic analysis of first-recurrence/metastasis esophageal squamous cell carcinoma: chemoimmunotherapy combined with radiotherapy as one of the optimal clinical management strategies

by Yitong Li, Qiaofang Li, Kuo Wang, Mengchang Gao, Lei Tian, Miaomiao Liu, Yuqing Bu, Yujie Cui
July 21, 2026

Related Content

Frontiers In Surgery

Intralesional ALA-PDT for residual extramammary Paget's disease: a case report

Jama Dermatology

Global Skin Cancer Burden From 1990 to 2023 and Projection to 2050

by Youyou Zhou, Weiming Zhong, Xulei Liu, Jianglin Zhang
July 1, 2026

Frontiers In Oncology

Clinical evaluation of large language model recommendations in melanoma: comparison with multidisciplinary tumor board decisions in a real-world cohort